Genecis Bioindustries Inc.
$30,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- September 1, 2019 – August 31, 2020
- Reference
- nrc-cnrc:172-2019-2020-Q2-933885
Published purpose
Genecis uses bacteria to make premium materials affordable. Our first product line is a biodegradable plastic resin known as PHA (polyhydroxyalkanoates) used for high-end applications, like 3D printing filaments. Our proprietary technology reduces the PHA resin production costs by 40% by offsetting feedstock cost, lowering the barrier for plastic manufacturers to create healthy and affordable products. To date, Genecis has scaled up to pilot scale, and cultivated bacteria which has conversion rates that exceeds standard paid feedstocks used by traditional PHA manufacturers. The objective of this project is to hire a Sales Manager to secure our initial licensing and purchase orders, and develop strong relationships with early adopters.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.